59th EASD Meeting 2023 - European Association for the Study of Diabetes

  • 02-06 Oct 2023
  • CCH - Congress Center Hamburg, Germany


The 59th EASD Meeting 2023 - European Association for the Study of Diabetes is a conference dedicated to diabetes and metabolism issues and covers topics such as: Genetics of diabetes, Prediction and prevention of diabetes, diabetes and Immunology, Insulin issues, Lipid metabolism, diabetes in childhood and diabetes complications.

The 59th EASD Meeting 2023 - European Association for the Study of Diabetes brings together physicians, scientists, nurses, laboratory workers and students interested in diabetes and related subjects.

The 59th EASD Meeting 2023 - European Association for the Study of Diabetes will be held in Hamburg on 02-06 October 2023.


  • CCH - Congress Center Hamburg , Marseiller Straße , Hamburg, Germany

More Details

55-750 Euro (Estimated)
The European Association for the Study of Diabetes (EASD)

Future Events

Past Events


Please, check the official event website for possible changes, before making any traveling arrangements

Event Categories

Health & Medicine: Diabetes, Genetics, Immunology, Metabolism
Science: Health sciences

Other Events with Similar Categories

Other Events with Similar Location or Organizer

Featured Conferences & Exhibitions

Articles / News / Press releases

Article content. Press on the above link to close

Introduction: Diabetes Mellitus (DM) is a public health problem worldwide. In this sense, the Query Diabetes was developed and implemented at the Day Hospital Diabetes (DHD) since 2010, by a multidisciplinary team whose aim is to provide the person with diabetes strategies for better understanding, respect and greater autonomy in the management of disease. A mission shared by internists, surgeons, nurses, dietician and social worker who during the sessions, evaluate patients individually and in group sessions.

Objective: To evaluate the efficacy of therapeutic intervention in people with diabetes education referenced to the DHD.

Methods: A longitudinal observational study of all patients referred to the Diabetes query during the 5-month period (January to May 2012). A questionnaire was administered before the first consultation and the other after the educational session (a second query). Finally became a statistical study based on Student`s t-test and Chi-Square test with statistical significance P <0.05.

Results: A total of 50 patients found that 52% were male and 48% of females. With an average age of 62.8 years and 14 years of evolution. Are already sick with various comorbidities, including psychiatric illness (36%), high blood pressure, hypertension (24%), dyslipidemia (4%) or the combination of several comorbidities (8%). The prevalence of chronic complications was 24% for diabetic retinopathy, nephropathy 25% to 15% for neuropathy, 21% for heart disease, 13% for peripheral arterial disease and 7% for cerebrovascular disease. At the end of 5 months after the educational intervention and drug, there was a reduction in HbA1c of 9.1% to 7.5% ± 2.2% ± 1.4% (p <0.001), an increase in the rate insulinization from 29.9% to 51.1% (p> 0.001), with no change in BMI.

Discussion / Conclusion: The therapeutic educaional Diabetes is an integral and crucial in the treatment of DM. A multidisciplinary assessment and delivery strategies to improve the relationship of the patient with the disease, along with pharmacological intervention, allowed a clear improvement of metabolic control.

Autores: S. Gonçalves, S. Estrela, A. Cardoso, C. Gonçalves.

Serviço: Hospital de dia de Diabetes; Directora: Dra. Cristina Gonçalves

Instituição: Centro Hospitalar do Médio Tejo